4basebio Plc - Holding(s) in Company
4basebio
1,316.67p
13:50 22/11/24
1.28%
16.67p
FTSE AIM All-Share
730.99
15:45 22/11/24
n/a
n/a
Pharmaceuticals & Biotechnology
20,137.98
15:45 22/11/24
3.64%
707.65
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: 4basebio PLC1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuer2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voting rightsXAn acquisition or disposal of financial instrumentsAn event changing the breakdown of voting rightsOther (please specify) iii: acting in concert under DTR 5.2.1(a) X3. Details of person subject to the notification obligation iv NameM&G plc (as indirect parent shareholder under DTR 5.1.2 and 5.2.1(e) and indirect holder of voting rights under DTR 5.2.1(a))City and country of registered office (if applicable)London, United Kingdom4. Full name of shareholder(s) (if different from 3.) vNameThe Prudential Assurance Company Limited (as direct shareholder) and Fort Aggregator, LP (as the other party to the agreement under DTR5.2.1(a)) City and country of registered office (if applicable)